Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Nexentis Technologies Inc.

Market Cap 3.71M 3.23M 3M 2.8M 5.26M 350M 5.29M 35.53M 13.77M 172M 13.92M 13.63M 598M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value 630K 550K 509K 477K 894K 59.48M 899K 6.04M 2.34M 29.28M 2.37M 2.32M 102M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
68.43%
Yield 2024 *
-
Yield 2025 -
1 day-4.87%
1 week+1.40%
Current month-8.96%
1 month+2.83%
3 months-6.73%
6 months-71.43%
Current year-56.80%
1 week 4.67
Extreme 4.67
6.47
1 month 4.18
Extreme 4.18
6.75
Current year 3.38
Extreme 3.38
14.21
1 year 3.38
Extreme 3.38
89.79
3 years 3.38
Extreme 3.38
4,047.41
5 years 3.38
Extreme 3.38
17,921.78
10 years 3.38
Extreme 3.38
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 2020-11-04
Director of Finance/CFO 39 2022-04-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 59 2021-01-11
Chairman 62 2021-05-23
Director/Board Member 47 2021-05-17
Date Insider Type Main position Quantity % Market Cap.
02-08Free

Chief Financial Officer

50,000 1.8639%
02-08Free

Chief Executive Officer

100,000 3.7279%
02-08Free

Chairman

116,286 4.3350%
Change 5-day change 1-year change 3-year change Capi.($)
-4.87%+1.40%-91.47%-99.54% 3.71M
+1.58%+4.98%+6.03%+37.32% 52.56B
+0.11%-.--%-.--%-.--% 12.96B
-1.26%-0.36%+89.84%+170.23% 11.63B
-2.18%-1.40%+30.61%+71.12% 7.97B
-1.91%-9.35%-24.08%-13.61% 6.63B
-7.19%-0.49%-13.39%+136.75% 6.55B
-0.50%+2.29%-4.76%-11.95% 5.47B
-0.46%+1.73%+30.59%+23.54% 4.84B
-1.40%+0.18%-32.15%-28.12% 4.58B
Average -1.81%+1.43%-0.88%+28.57% 11.32B
Weighted average by Cap. -0.17%+2.82%+11.78%+46.23%

Financials

2024 2025
Net sales 210K 183K 170K 159K 298K 19.82M 300K 2.01M 780K 9.75M 788K 771K 33.87M -
Net income -5.19M -4.53M -4.19M -3.93M -7.36M -490M -7.41M -49.75M -19.28M -241M -19.49M -19.07M -837M -4M -3.49M -3.23M -3.03M -5.68M -378M -5.71M -38.36M -14.87M -186M -15.03M -14.71M -646M
Net Debt -2.48M -2.17M -2.01M -1.88M -3.52M -234M -3.54M -23.81M -9.23M -115M -9.33M -9.13M -401M -3.08M -2.68M -2.49M -2.33M -4.37M -291M -4.39M -29.5M -11.43M -143M -11.56M -11.31M -497M
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
26-06-18 5.080 $ -4.87% 90,232
26-06-17 5.340 $ -8.25% 4,762,317
26-06-16 5.820 $ +5.05% 6,346,820
26-06-15 5.540 $ +15.42% 38,342
26-06-12 4.800 $ -4.19% 14,399
  1. Stock Market
  2. Stocks
  3. NXTS Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!